Coalition of U.S. Women’s Health and HIV Advocates Call for Accelerated US Government Plan for Demonstrating Feasibility of PrEP for Women

March 4, 2013 - Atlanta, GA.  The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in your inbox.

seventh name

Treatment 103: The Basics of Clinical Trials and Bio-Medical Research was the sixth in our eight-week webinar series that offers women living with HIV capacity building and training on HIV disease and treatment advocacy.

Get some great tips about traveling with HIV. Learn about packing your pills, adjusting your dosing schedule, and traveling abroad.

Obtener información acerca de la profilaxis pre-exposición (PrEP), cómo funciona, lo que dice la investigación, las nuevas directrices para el uso de Truvada como PrEP, y mucho más.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>